SK Holdings has entered a strategic partnership with the pharmaceutical company builder as the latter unveils a new targeted protein degradation platform.

Asahi Intecc, Dai-Dan, StemCell Institute and Taiko Pharmaceutical all took part in a $19.3m round for the cell-derived heart therapy developer.

Spinout Space has secured a $250,000 grant from Bank of America Charitable Foundation to incubate nascent WSU life science projects.

Returning investor Tigermed helped the cancer and rare disease therapy developer close a round that will support commercialisation of its Hunter syndrome drug.

So-Young International was among the investors in a $30.6m round for LinkedCare, a developer of medical clinic management software.

Kyoto University Innovation Capital has taken part in a $19.3m round for the cell-derived heart therapy spinout of Osaka University.

Roivant Sciences has acquired University of Michigan spinout Oncopia Therapeutics.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

XtalPi has invested in collaboration partner Metis Pharamceuticals, which is targeting disorders including endometriosis and uterine fibroids.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.